USA Financial Formulas’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.3K Buy
657
+498
+313% +$64.8K 0.02% 187
2026
Q1
$15.6K Buy
159
+147
+1,225% +$13.9K ﹤0.01% 276
2025
Q4
$890 Buy
+12
New +$854 ﹤0.01% 307
2024
Q2
Sell
-468
Closed -$66.7K 306
2024
Q1
$66.7K Buy
+468
New +$61.3K 0.01% 228
2022
Q1
Sell
-845
Closed -$101K 353
2021
Q4
$101K Buy
+845
New +$86K 0.09% 120
2021
Q3
Sell
-2,180
Closed -$127K 402
2021
Q2
$127K Sell
2,180
-613
-22% -$43.9K 0.11% 156
2021
Q1
$197K Sell
2,793
-996
-26% -$57.4K 0.16% 122
2020
Q4
$162K Buy
+3,789
New +$144K 0.13% 135
2019
Q1
Sell
-7,841
Closed -$381K 135
2018
Q4
$381K Sell
7,841
-322
-4% -$12.5K 0.09% 157
2018
Q3
$373K Buy
+8,163
New +$383K 0.09% 175

Other funds holding ARCB

USA Financial Formulas's ARCB Position: Q2 2026 in Review

USA Financial Formulas increased its ArcBest (ARCB) stake by 313% in Q2 2026, buying an estimated $64.8K and bringing the position to 657 shares worth $94.3K. The position accounts for 0.02% of the portfolio, ranked #187.

USA Financial Formulas first reported a position in ARCB in Q3 2018 and has held it in 10 quarters since. The position peaked at $381K in Q4 2018. 332 funds tracked by Wall St. Rank hold ARCB as of Q2 2026.

  • USA Financial Formulas held 657 shares of ArcBest worth $94.3K as of Q2 2026.
  • USA Financial Formulas bought 498 ArcBest shares in Q2 2026, an estimated $64.8K.
  • ArcBest made up 0.02% of USA Financial Formulas's portfolio in Q2 2026, its #187 holding.
  • USA Financial Formulas first reported a position in ArcBest in Q3 2018 and has held it in 10 quarters since.
  • USA Financial Formulas's ArcBest position peaked at $381K in Q4 2018.
  • 332 funds tracked by Wall St. Rank held ArcBest as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.